RK-4
Clinical trials for RK-4 explained in plain language.
Never miss a new study
Get alerted when new RK-4 trials appear
Sign up with your email to follow new studies for RK-4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone marrow injection shows promise for severe stroke
Disease control Not yet recruitingThis early-phase study tests a new drug called RK-4 for people with a severe type of stroke (large hemispheric infarction) who cannot have standard clot-removal treatment. The drug is injected directly into the skull bone marrow once daily for three days. The main goals are to ch…
Matched conditions: RK-4
Phase: PHASE1, PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Bone marrow injection into skull shows promise for severe stroke recovery
Disease control Not yet recruitingThis study tests a new drug called RK-4, injected directly into the skull bone marrow, for people with a severe type of stroke (large hemispheric infarction) who cannot have standard blood vessel treatments. About 194 participants will either get the RK-4 injection daily for 3 da…
Matched conditions: RK-4
Phase: PHASE2 • Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC